IRVINE, Calif., June 04, 2021 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced that it will be participating in two upcoming investor conferences: the Truist Life Sciences Series and LD Micro Invitational… Read More
News
Biomerica’s Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab
Less invasive nasal swab taken from front opening of the nose is more comfortable for patients Test can be performed by doctors, school and company nurses, and medical assistants, in any location without specialized equipment IRVINE, Calif., May 11, 2021… Read More
Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020
Sales increase driven by first sales of COVID-19 Antigen Rapid Test in Europe after January 2021 CE Mark approval Awarded two new patents for InFoods diagnostic guided therapy technology, including the first Japanese patent InFoods IBS diagnostic-guided therapy clinical trial expecting top… Read More
Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
Biomerica expects completion of enrollment of its Irritable Bowel Syndrome Diagnostic-Guided Therapy clinical trial by end of April, 2021 FDA actively reviewing Company’s EUA submission for its first of its kind “at-home” Blood Collection kit used with the Biomerica COVID-19… Read More
Biomerica CE Mark COVID-19 Antigen Rapid Test
Download PDF
Biomerica Reports Fiscal 2021 1st Quarter Financial Results
Download PDF